about
Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidenceEffect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapyThe release of prolactin by medroxy-progesterone acetate in human subjects.Evidence for a nonprolactin, non-growth-hormone mammary mitogen in the human pituitary gland.Description of the time course of the prolactin suppressant effect of the dopamine agonist CQP201-403 by an integrated pharmacokinetic-pharmacodynamic model.Augmentation of prolactin secretion by estrogen in hypogonadal womenFunctional evaluation of prolactin secretion: a guide to therapy.Functional evaluation of prolactin secretion in patients with hypothalamic-pituitary disorders.Endocrine studies in anencephaly.Hypothalamic-pituitary function in diverse hyperprolactinemic states.Effect of guanfacine on pituitary hormones in man.Changing concepts of prolactin in man.Hypothyroidism presenting with hyperprolactinaemia.Radioimmunoassay of human prolactin.The ontogenesis of human fetal hormones. III. ProlactinFamilial hypogonadotropic hypogonadism with alopeciaEffect of insulin-induced hypoglycemia on the serum concentrations of thyroxine, triiodothyronine and reverse triiodothyronine.Prolactin-secreting pituitary adenomas in males: transsphenoidal microsurgical treatment.Isolated thyrotropin deficiency due to a pituitary tumourEffect of somatostatin on thyrotropin, prolactin, growth hormone and insulin responses to thyrotropin releasing hormone and arginine in healthy, hypothyroid and acromegalic subjects.Stimulators and inhibitors of hepatic porphyrin formation in human sera.The effect of levodopa on galactorrhea in the Forbes-Albright syndrome.The effect of dexamethasone on TSH and prolactin secretion after TRH stimulation.Treatment of prolactin producing pituitary adenomas.Localization of prolactin in chromophobe pituitary adenomas: study of human necropsy material by immunoperoxidase technique.Galactorrhoea amenorrhoea syndrome due to internal carotid artery aneurysm.Lactation and the physiology of prolactin secretion.Suppression of androgen production by D-tryptophan-6-luteinizing hormone-releasing hormone in man.Review: human prolactin--recent advances in physiology and therapy.Endochondral bone growth, bone calcium accretion, and bone mineral density: how are they related?Flutroline in the treatment of the schizophrenic patient.Hyperprolactinemia: neuroendocrine and diagnostic aspects.Studies on the determination of plasma prolactin.Diagnostic work-up of hyperprolactinemic disorders.Drug-induced changes in prolactin secretion. Clinical implications.Bromocriptine suppression of the thyrotrophin response to thyrotrophin releasing hormone.Maternal serum prolactin and its response to TRH in normal and complicated early pregnancy.Chronic dopamine receptor stimulation using bromocriptine: failure to modify thyroid function.Episodic and TRH induced growth hormone release in primary hypothyroidism of man and rat.Adrenal androgens in patients with chronic marked elevation of prolactin.
P2860
Q24682605-6173B6D1-41FA-44F1-ADB6-DE3F773AA1F5Q28335246-72EC91B1-0EFF-4902-9EE7-7F0BE9431FFCQ34236106-00EBC338-20F1-4D84-8A08-B3EAF9D98527Q34366967-2F667EFA-FEC7-4FA4-97BC-BD1036D48661Q34447828-D18AC6E8-0E11-430F-9A1B-1EB8F9FEFEF6Q34462499-26FD944F-A181-43BC-88B9-2ABA6ED599EFQ34494876-608A4610-BBF9-4C83-8C68-19E7D22BD719Q34501953-69516791-4218-4605-BBE2-BE21ACF73012Q34507285-15056697-7B73-46D2-8215-94D01F13137FQ34518805-07C9B00C-5D18-401E-AD2B-5B8CD4D767EAQ34519244-8B37D9F8-3095-4043-8ACB-428FD71CD553Q34584843-405D193A-46A5-4542-A5D4-3731476ED3D8Q34991940-1D15D89D-7A45-4F5B-8A7E-AF70E43E126CQ35144677-1634B399-30D2-4400-8B23-E897F58C1469Q35194342-B14CD982-1D24-4C4E-89F9-14B9D670EBDAQ35228234-B5F068E5-E5AE-44F0-81F8-428C5B51CED0Q35229196-C75A98F5-DBCC-402F-A1DB-F33CE5973408Q35644923-781F1D0B-2EDF-4407-BABB-61F12D7C75CBQ35815593-C6A624F5-8D90-42B5-9C92-22417BA28A5EQ35817112-62B730AC-4005-47AF-9671-4104763AA875Q35901449-56204109-1F0A-49DC-BAE2-92E9E70E6052Q35926889-71107EF8-D3AF-45CA-A083-2A5D89BF6371Q35957313-109DD348-65E6-41B6-BEEA-2CF1D0DC405FQ36518578-4B18B8D3-8FDD-484E-B61A-3971E52D92C0Q36597487-4A21CDED-B901-43DB-BA39-6246D785466BQ36706381-F46DAF8B-18FC-4A0E-836C-8F73B80D63AFQ36810641-56AFECAE-25B3-443A-9803-0EE18EE8578DQ37003677-EEA9E806-2F81-40ED-B285-3E61B5E25520Q37674340-B90F5901-8FC4-4530-9CEE-438F20F614CCQ38013036-398E4C0C-CBEA-4D9F-A865-BA8F7FC9B03EQ38584524-00A1A061-EA86-4C0B-91A5-C85E68DB2B13Q38724656-03B60FCE-4B35-4F7E-80D4-7F83DC70760BQ39241867-3DDE7EC4-A0FA-49A8-8924-61A70126E1ABQ39472556-6F306797-F16A-4A05-9931-A4F7C3D4DC27Q39555712-BA6B29F2-2002-4EC9-A417-0B6DC3530480Q39622813-8508CA61-C079-4753-8004-FF088C9E7118Q39682394-88D7DA83-8FED-439D-BDDB-676433D21E5EQ39703958-749D309F-1F2D-4FF8-9420-61824D1A1414Q39704161-26EB33D9-9727-4029-8A84-715ECE7162A0Q39843993-30E3920F-656E-4C63-B03A-F46BB0F76493
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1971
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A radioimmunoassay for human prolactin.
@en
A radioimmunoassay for human prolactin.
@nl
type
label
A radioimmunoassay for human prolactin.
@en
A radioimmunoassay for human prolactin.
@nl
prefLabel
A radioimmunoassay for human prolactin.
@en
A radioimmunoassay for human prolactin.
@nl
P2093
P2860
P356
P1476
A radioimmunoassay for human prolactin.
@en
P2093
P2860
P304
P356
10.1073/PNAS.68.8.1902
P407
P577
1971-08-01T00:00:00Z